Sign In
Buy INVVY
$21.85
+0 (+0%)
At Close: Sep 08, 2023
Medicaid and commercially insured patients with high adherence to SUBLOCADE® experienced lower relapse rates and reduced healthcare resource utilization Adherence to SUBLOCADE was associat
Indivior PLC (INDV) Q3 2025 Earnings Call Transcript
03:56pm, Thursday, 30'th Oct 2025
Indivior PLC ( INDV ) Q3 2025 Earnings Call October 30, 2025 8:00 AM EDT Company Participants Jason Thompson - Vice President of Investor Relations Joseph Ciaffoni - CEO & Director Patrick Barry - Chi
Here's Why Indivior Stock Soared 15% Today
02:18pm, Thursday, 30'th Oct 2025
Indivior is already profitable and cash-generative, and is set to grow significantly in 2026. Its key medication's delivery system offers opioid use disorder patients more reliable outcomes.
Indivior PLC (INDV) Beats Q3 Earnings and Revenue Estimates
09:31am, Thursday, 30'th Oct 2025
Indivior PLC (INDV) came out with quarterly earnings of $0.72 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.54 per share a year ago.
Indivior Reports Third Quarter 2025 Financial Results and Raises Full-Year 2025 Financial Guidance
07:00am, Thursday, 30'th Oct 2025
Q3'25 Total Net Revenue of $314m, up 2% YOY; Q3'25 SUBLOCADE® Net Revenue of $219m, up 15% YOY Announces the Optimization of Rest of World (ROW) Business Discontinued the Sales and Marketing Support
Indivior to Participate in the Stifel 2025 Healthcare Conference
10:00am, Tuesday, 28'th Oct 2025
RICHMOND, Va. , Oct. 28, 2025 /PRNewswire/ -- Indivior PLC (NASDAQ: INDV) today announced that it will participate in the Stifel 2025 Healthcare Conference: Stifel 2025 Healthcare Conference – New
Indivior to Report Third Quarter 2025 Financial Results and Host Webcast on October 30th
04:04pm, Thursday, 16'th Oct 2025
RICHMOND, Va. , Oct. 16, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq: INDV) today announced that it will report its third quarter 2025 financial results on Thursday, October 30, 2025, at 7:00 a.m.
UK's Indivior to re-domicile to US after listing move
09:35am, Wednesday, 01'st Oct 2025
Indivior , said on Wednesday it plans to relocate its corporate domicile from the UK to the United States, establishing a new Delaware-based parent company, just months after the pharmaceutical firm m
Indivior Proposes New Corporate Structure to Achieve U.S. Domiciliation
08:00am, Wednesday, 01'st Oct 2025
RICHMOND, Va. , Oct. 1, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq: INDV) ("Indivior PLC" or the "Company") today announced that it intends to pursue a change in domicile from the U.K. to the U.S. and
What Makes Indivior PLC (INDV) a Strong Momentum Stock: Buy Now?
01:01pm, Wednesday, 10'th Sep 2025
Does Indivior PLC (INDV) have what it takes to be a top stock pick for momentum investors? Let's find out.
Indivior PLC (INDV) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
11:44am, Monday, 08'th Sep 2025
Indivior PLC (NASDAQ:INDV ) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 9:15 AM EDT Company Participants Joseph Ciaffoni - CEO & Director Ryan Preblick - Chief Financial
Indivior to Participate in Upcoming Investor Events
12:00pm, Wednesday, 20'th Aug 2025
RICHMOND, Va. , Aug. 20, 2025 /PRNewswire/ -- Indivior PLC (NASDAQ: INDV) today announced that it will participate in the following investor events: Morgan Stanley 23rd Annual Global Healthcare Confe
Indivior's Strategic Turnaround Gains Traction Post-Q2 2025
05:39pm, Tuesday, 05'th Aug 2025
Indivior's turnaround is driven by SUBLOCADE's strong growth, improved cash flow, and a three-phase recovery plan that the market undervalues. Q2 2025 results beat expectations, with SUBLOCADE deliver
All You Need to Know About Indivior (INDV) Rating Upgrade to Strong Buy
01:01pm, Tuesday, 05'th Aug 2025
Indivior (INDV) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Indivior PLC (INDV) Q2 2025 Earnings Call Transcript
05:22am, Friday, 01'st Aug 2025
Indivior PLC (NASDAQ:INDV ) Q2 2025 Earnings Conference Call July 31, 2025 8:00 AM ET Company Participants Jason Thompson - Vice President of Investor Relations Joseph J. Ciaffoni - CEO & Director Pat
